Skip to main content

Try Mindfulness, Talk Therapy to Ease Mood, Memory Issues of Menopause

Medically reviewed by Carmen Pope, BPharm. Last updated on Feb 28, 2024.

By Dennis Thompson HealthDay Reporter

WEDNESDAY, Feb. 28, 2024 -- Mindfulness meditation and cognitive behavioral therapy can help ease the mood and sleep problems associated with menopause, a new review says.

Women experienced statistically significant improvements in anxiety and depression following mindfulness therapy and cognitive behavioral therapy, according to an analysis of 30 studies involving more than 3,500 women going through menopause in 14 countries.

The results show that therapy can be as valuable as hormone replacement therapy in helping women deal with menopause symptoms, the researchers concluded.

“[General practitioners] and healthcare providers often struggle to know what to offer beyond medical treatment,” said senior researcher Roopal Desai, a fellow in psychology with University College London. “This research will help give GPs and patients more options.”

Mindfulness meditation teaches people to be intensely aware of what they are sensing and feeling in the moment, using breathing methods and other practices to relax the body and mind.

On the other hand, cognitive behavioral therapy (CBT) teaches people to recognize negative thoughts and behaviors that occur in response to challenging situations, and to adjust their responses to be more positive and beneficial.

The evidence review uncovered 10 studies looking at the impact of cognitive behavioral therapy on menopause symptoms, and nine evaluating the helpfulness of mindfulness meditation.

Another eleven studies reviewed other therapy techniques, including group counseling, marital support, health coaching and emotional freedom techniques.

Not only did CBT and mindfulness improve mood, but these therapies also were effective in reducing menopause-related “brain fog” difficulties with memory and concentration.

The results suggest that CBT is the most cost-effective option for menopause management, researchers said. Compared to other options, it requires a shorter course of treatment -- around 1.5 hours per session and nearly 12 hours total.

The new study was published Feb. 27 in the Journal of Affective Disorders.

The researchers noted these findings fall in line with guidelines recommending that CBT be considered alongside hormone replacement therapy or as an alternative to it.

“Menopause management is now a prioritized topic in public health,” said lead researcher Aimee Spector, a professor of clinical psychology of aging with University College London. “However, most studies of menopause symptom management focus on hormonal replacement therapy and physiological symptoms.”

“This restricts treatment options for women who are concerned about the risks of hormone replacement therapy and overlooks the well-being of women with non-physiological symptoms, such as brain fog and mood problems, which are highly prevalent,” Spector said in a university news release.

Sources

  • University College London, news release, Feb. 27, 2024

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

Americans' Interest in Microdosing Psychedelics Is Growing

MONDAY, July 1, 2024 -- A study based on online Google searches suggests surging U.S. interest in microdosing psychedelics, such as psilocybin, as rules around the use of such...

Magic Mushroom's Psilocybin Is America's Most Popular Hallucinogen

THURSDAY, June 27, 2024 -- As psilocybin mushrooms become the most popular psychedelic in the United States, some states have started to ease regulations on its recreational...

Anxiety Tied to Doubling of Parkinson's Risk

WEDNESDAY, June 26, 2024 -- Anxiety could be an early warning sign of Parkinson's disease, a new study finds. People with anxiety have at least double the risk of developing...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.